Streetbeat News

Regulatory

MRK

The FDA has approved Merck & Co Inc's cancer drug, Keytruda, for use in treating locally advanced unresectable or metastatic biliary tract cancer (BTC). The approval was based on results from the Phase 3 KEYNOTE-966 trial, which showed a significant improvement in overall survival rates. This marks the sixth indication for Keytruda in gastrointestinal cancers. Merck also released data from the Phase 3 KEYNOTE-564 trial evaluating Keytruda for certain patients with renal cell carcinoma.

Portfolio Pulse from Vandana Singh

November 01, 2023 | 5:51 pm

EGPT

EIS

SPY

USO

The U.S. State Department has announced that an initial group of foreign nationals, including Americans, have left Gaza on Wednesday. More U.S. citizens and foreign nationals are expected to leave Gaza, and more aid trucks are expected to enter Gaza through Rafah today.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:48 pm

CLGN

CollPlant Biotechnologies has been granted a patent by the U.S. Patent and Trademark Office for its photocurable dermal filler product candidate, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:03 pm

CURO

CURO Group Holdings has received a continued listing standard notice from the NYSE, which has led to an increase in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:58 pm

BSGM

BioSig Technologies has been awarded several new utility patents by the U.S. Patent and Trademark Office. These patents cover the company's PURE EP digital signal processing technology. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:56 pm

SPY

Stanley Druckenmiller, who runs Duquesne Family Office, criticized the federal government for its spending habits, stating that it will negatively impact the markets. He noted that government spending has increased from 20% to 25% of GDP since the pandemic. He also expressed concern over the Biden administration's request for $106 billion in aid for Ukraine and Israel, and an additional $56 billion for emergency spending. Druckenmiller believes that these spending habits will lead to challenging times for the markets, especially given the geopolitical landscape and historically high multiples.

Portfolio Pulse from Adam Eckert

November 01, 2023 | 4:39 pm

EIS

SPY

U.S. President Biden has announced that American citizens will be evacuated from Gaza on Wednesday. The news does not directly mention any US-listed companies or ETFs.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 4:30 pm

LFLY

A study shows that home prices in states that have legalized recreational cannabis have surged $48,983 higher in the past decade compared to other states. In 23 states and Washington, D.C. where recreational marijuana use is legal, property values have risen by $185,075 since 2014, compared to $136,092 in states without. The study was conducted by Real Estate Witch, an online publication owned by Clever Real Estate, and Leafly, a leading online cannabis discovery marketplace. Leafly Holdings Inc (NASDAQ:LFLY) highlighted the benefits of recreational sales.

Portfolio Pulse from Jelena Martinovic

November 01, 2023 | 4:29 pm

AMZN

GOOG

IBM

META

MSFT

NVDA

PLTR

TSLA

Vice President Kamala Harris spoke at the U.K. AI Safety Summit, emphasizing the potential of AI for good and the need for regulation to prevent harm. She announced the AI Safety Institute, an AI Bill of Rights, and a commitment to responsible AI use by militaries. Harris also mentioned that 30 countries and 10 top philanthropies have joined the U.S. in these commitments. Key figures from companies like Tesla, OpenAI, Palantir Technologies, Nvidia, Microsoft, Alphabet, Meta Platforms, Amazon, Anthropic, IBM, and Samsung are expected to attend the event.

Portfolio Pulse from Chris Katje

November 01, 2023 | 4:05 pm